SELLAS Life Sciences Group, Inc. (SLS) Total Assets by Year
SELLAS Life Sciences Group, Inc. closed fiscal year 2025 with $78.3M in total assets, $7.5M in total liabilities and $70.9M in shareholder equity. This represents an increase of 303.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters SELLAS Life Sciences Group, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SLS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $78.3M+303.2% | $19.4M+212.5% | $6.2M-70.3% | $20.9M-20.3% | $26.3M-42.9% | $46.0M+177.3% | $16.6M-1.8% | $16.9M-49.5% | $33.5M+422.2% | $6.4M-92.2% | $82.1M+2.1% | $80.5M-8.5% | $88.0M+60.0% | $55.0M+77.6% | $31.0M |
| Total Liabilities | $7.5M-25.0% | $10.0M-29.8% | $14.2M-11.8% | $16.1M+171.5% | $5.9M-67.2% | $18.1M+72.0% | $10.5M-9.9% | $11.7M-62.9% | $31.5M+175.5% | $11.4M-87.9% | $94.4M+117.4% | $43.4M-47.1% | $82.1M+201.5% | $27.2M+30.6% | $20.9M |
| Total Equity | $70.9M+648.8% | $9.5M+218.7% | -$8.0M-264.4% | $4.9M-76.2% | $20.3M-27.2% | $28.0M+358.9% | $6.1M+16.2% | $5.2M+153.4% | $2.1M+141.4% | -$5.0M+59.2% | -$12.3M-133.1% | $37.1M+529.6% | $5.9M-78.8% | $27.8M+174.5% | $10.1M |
SLS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $145.4M+350.0% | $114.2M+226.6% | $78.3M+303.2% | $51.6M+94.5% | $32.3M+113.7% | $35.0M+43.1% | $19.4M+212.5% | $26.5M+227.8% | $15.1M-18.6% | $24.4M-16.0% | $6.2M-70.3% | $8.1M-68.9% |
| Total Liabilities | $7.7M+25.5% | $6.8M-6.0% | $7.5M-25.0% | $5.9M-44.2% | $6.2M-49.6% | $7.2M-51.2% | $10.0M-29.8% | $10.6M-10.9% | $12.2M-11.1% | $14.8M-7.4% | $14.2M-11.8% | $11.9M-11.1% |
| Total Equity | $137.7M+426.4% | $107.4M+286.9% | $70.9M+648.8% | $45.6M+187.1% | $26.1M+797.7% | $27.8M+186.6% | $9.5M+218.7% | $15.9M+515.3% | $2.9M-39.9% | $9.7M-26.5% | -$8.0M-264.4% | -$3.8M-130.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More SELLAS Life Sciences Group, Inc. financials
Frequently Asked Questions
What was SELLAS Life Sciences Group, Inc.'s total assets in fiscal year 2025?
SELLAS Life Sciences Group, Inc. closed fiscal year 2025 with $78.3M in total assets, $7.5M in total liabilities and $70.9M in shareholder equity.
How fast is SELLAS Life Sciences Group, Inc.'s total assets growing?
SELLAS Life Sciences Group, Inc. (SLS) total assets rose by 303.2% year over year, from $19.4M to $78.3M in fiscal year 2025.
How has SELLAS Life Sciences Group, Inc.'s total assets changed over the years?
Across the 15 fiscal years this page covers, SELLAS Life Sciences Group, Inc. (SLS) total assets went from $31.0M in fiscal year 2011 to $78.3M in fiscal year 2025.
What was SELLAS Life Sciences Group, Inc.'s total assets in the most recent quarter?
SELLAS Life Sciences Group, Inc. (SLS) reported $145.4M in total assets in Q2 2026. This represents an increase of 350.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what SELLAS Life Sciences Group, Inc. (SLS) reported on that line in every period on record.